Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression

Applied Immunohistochemistry and Molecular Morphology

Volumn 10, Issue 4, 2002, Pages 289-295

  Lee, Ji Shin ^a   Kim, Hyung Seok ^a   Jung, Jong Jae ^a   Kim, Young Bog ^a   Lee, Min Cheol ^b   Park, Chang Soo ^b  

^a Seonam University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Angiogenesis; Breast cancer; HER 2 neu; P53; Vascular endothelial growth factor

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOPROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036900803     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200212000-00001     Document Type: Article

References (38)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-36.
3. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-4.
4. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12:454-66.
5. Martin L, Green B, Renshaw C. et al. Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 1997;76:1046-54.
6. Gasparini G, Toi M, Verderio P, et al. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: Subanalysis in node-positive and node-negative patients. Int J Oncol 1998;12:1117-25.
7. Siitonen SM, Haapasalo HK, Rantala IS, et al. Comparison of different immunohistochemical methods in the assessment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 1995;8:745-52.
8. Axelsson K, Ljung BM, Moore DH, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:997-1008.
9. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
10. Abulafia O, Triest WE, Sherer DM. Angiogenesis in malignancies of the female genital tract. Gynecol Oncol 1999;72:220-31.
11. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
12. Guidi AJ, Schnitt SJ, Fischer L, et al. Vascular permeability factor (vascular endothelial growth factor) expression in patients with ductal carcinoma in situ of the breast. Cancer 1997;80:1945-53.
13. Lee AH, Dublin EA, Bobrow LG, et al. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol 1998;185:394-401.
14. Gasparini G, Toi M, Gion M, et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 1997;89:139-47.
15. Obermair A, Kucera E, Mayerhofer K, et al. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival. Int J Cancer 1997;74:455-8.
16. Callagy G, Dimitriadis E, Harmey J, et al. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer: A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor. Appl Immunohistochem Molecul Motphol 2000;8:104-9.
17. Linderholm B, Lindh B, Tavelin B, et al. p53 and vascularendothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000; 89:51-62.
18. Linderholm BK, Lindahl T, Holmberg L, et al. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res 2001;61: 2256-60.
19. Dameron KM, Volpert OV, Tainsky MA, et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-4.
20. Kieser A, Weich HA, Brandner G, et al. p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994;9:963-9.
21. Petit AM, Rak J, Hung MC, et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinase downregulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997;151: 1523-30.
22. Yen L, You XL, Al Moustafa AE, et al. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene 2000;19:3460-9.
23. Marks JR, Humphrey PA, Wu K, et al. Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. Ann Surg 1994;219:332-41.
24. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of breast carcinoma. Hum Pathol 1996;27:220-4.
25. rd Ed. Philadelphia: JB Lippincott, 1989.
26. Mason DY, Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labeling of cellular constituents. J Clin Pathol 1978;31:454-60.
27. Lee JS, Kim HS, Jung JJ, et al. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression. J Surg Oncol 2001;77:55-60.
28. Rudolph P, Alm P, Olsson H, et al. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer. Hum Pathol 2001;32:311-9.
29. Barbareschi M, Leonardi E, Mauri FA, et al. p53 and c-erbB-2 protein expression in breast carcinomas: An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Am J Clin Pathol 1992;98:408-31.
30. Lee JS, Kim HS, Jung JJ, et al. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior. Anal Quant Cytol Histol 2001;23:161-8.
31. Kondo Y, Aril S, Furutani M, et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer 2000;88:1820-7.
32. Riedel F, Götte K, Schwalb J, et al. Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngol 2000;120:105-11.
33. Saito H, Tujitani S, Ikeguchi M, et al. Neoangiogenesis and relation to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. Laboratory Inv 1999;57:164-72.
34. Weidner N. Tumoral vascularity as a prognostic factor in cancer patients: The evidence continues to grow. J Pathol 1998;184: 119-22.
35. Barbareschi M, Gasparini G, Morelli L, et al. Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat 1995;36:181-92.
36. Lee JS, Jung JJ, Kim J. Quantification of angiogenesis by a computerized image analysis system in renal cell carcinoma. Anal Quant Cytol Histol 2000;22:469-74.
37. Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995;55:6161-5.
38. Strohmeyer D, Rössing C, Bauerfeind A, et al. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate 2000;45:216-24.